Literature DB >> 2757909

Effects of vigabatrin and of GABA on myelinated rat cerebellar cultures: preliminary data.

J J Hauw1, J M Boutry, P Sun, V Sazdovitch, C Duyckaerts.   

Abstract

1. The aim of this study was to evaluate the effect of high concentrations of vigabatrin (gamma-vinyl GABA) and of GABA on myelin of the central nervous system cultures. 2. Explants of rat cerebellum were cultured for 14-19 days in vitro on collagen-coated coverslips in Leighton tubes. They were exposed for up to 14 days to 500 nmol ml-1 vigabatrin or to 1000 nmol ml-1 GABA. 3. Qualitative and quantitative blind examination of living cultures and of Sudan black B-stained slides showed mild toxicity of both drugs for myelinated fibres. No clear-cut differences could be demonstrated between the two compounds, although vigabatrin seemed slightly more toxic than GABA at these doses. 4. In electron microscopy, no patent intramyelinic oedema nor primary demyelination were seen. On the contrary, some degenerating myelinated fibres and astrocytic gliosis were seen in both experimental conditions. The changes involved axons as well as myelin sheaths. 5. The toxicity of GABA and vigabatrin was surprisingly mild in this very sensitive model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757909      PMCID: PMC1379679          DOI: 10.1111/j.1365-2125.1989.tb03461.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes.

Authors:  M B BORNSTEIN
Journal:  Lab Invest       Date:  1958 Mar-Apr       Impact factor: 5.662

2.  Morphology of cultured guinea-pig cerebellum. I. Pattern of development. Comparison of phase contrast cinematography and silver impregnations of various cell types.

Authors:  J J Hauw; J M Boutry; N Crosnier-Suttin; R Robineaux
Journal:  Cell Tissue Res       Date:  1974       Impact factor: 5.249

3.  Culture of nervous tissue on collagen in Leighton tubes.

Authors:  J J Hauw; A B Novikoff; P M Novikoff; J M Boutry; R Robineaux
Journal:  Brain Res       Date:  1972-02-25       Impact factor: 3.252

4.  Omega-aminoaciduria induced by gamma-vinyl GABA.

Authors:  N J Brandt; E Christensen
Journal:  Lancet       Date:  1984-02-25       Impact factor: 79.321

5.  The neuropathology of vigabatrin.

Authors:  J J Hauw; S Trottier; J M Boutry; P Sun; V Sazdovitch; C Duyckaerts
Journal:  Br J Clin Pract Suppl       Date:  1988-03

6.  Total GABA and homocarnosine in CSF as indices of brain GABA concentrations.

Authors:  M G Palfreyman; S Huot; J Grove
Journal:  Neurosci Lett       Date:  1983-02-21       Impact factor: 3.046

7.  Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy.

Authors:  P J Schechter; N F Hanke; J Grove; N Huebert; A Sjoerdsma
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

8.  Vigabatrin: no microvacuoles in a human brain.

Authors:  B Pedersen; K Højgaard; M Dam
Journal:  Epilepsy Res       Date:  1987-01       Impact factor: 3.045

9.  Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid).

Authors:  J Grove; P J Schechter; G Tell; J Koch-Weser; A Sjoerdsma; J M Warter; C Marescaux; L Rumbach
Journal:  Life Sci       Date:  1981-05-21       Impact factor: 5.037

10.  Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin.

Authors:  R A John; E M Rimmer; J Williams; G Cole; L J Fowler; A Richens
Journal:  Biochem Pharmacol       Date:  1987-05-01       Impact factor: 5.858

View more
  1 in total

1.  Abnormal axial diffusivity in the deep gray nuclei and dorsal brain stem in infantile spasm treated with vigabatrin.

Authors:  G N Simao; S Zarei Mahmoodabadi; O C Snead; C Go; E Widjaja
Journal:  AJNR Am J Neuroradiol       Date:  2010-08-26       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.